[Edaily Starin Choi Hee-jae Reporter] The sentencing hearing for Mr. A, who has been charged with stalking actor Hwang Jung-min, is set to take place. Hwang Jung-min (Photo = E-Daily DB) The Goyang Branch of the Uijeongbu District Court will hold a sentencing hearing on the 11th for Mr. A, who has been charged with violations of the Anti-Stalking Act and other offenses. The prosecution is expected to present its sentencing recommendation during the hearing. Hwang Jung-min filed a complaint against Mr. A last August on charges including violation of the Anti-Stalking Act. In February, the court issued a summary order fining Mr. A 3 million won, but Mr. A appealed the decision, claiming innocence and requesting a full trial. Mr. A has continued to make revelations by releasing text messages and recorded phone calls exchanged with a man believed to be Hwang Jung-min via social media. Mr. A has consistently denied the stalking charges, arguing that his relationship with Hwang Jung-min was mutual, not one-sided. On the 29th of last month, Ms. A raised allegations of an extramarital affair with Hwang Jung-min via social media, and the claims spread through online communities and social media platforms. In response, Hwang Jung-min’s agency, Sam Company, issued an official statement, saying, “Ms. A is a suspect in a stalking crime who has continuously harassed Hwang Jung-min,” and added, “The court imposed provisional measures, including a restraining order, on the suspect on three separate occasions and issued a summary order imposing a fine of 3 million won after acknowledging the stalking charges.” Mr. A denied the stalking allegations and signaled his intention to contest the matter in court. Regarding Hwang Jung-min’s criminal complaint against him, he stated, “I have appealed this decision, asserted my innocence, and requested a formal trial,” adding, “There is no final guilty verdict.” He also noted that he is currently pursuing a civil lawsuit against Hwang Jung-min seeking damages for tortious conduct.
The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…